Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Phase 3 Study Supports Use of Teprotumumab for Thyroid Eye Disease
October 14th 2019Raymond Douglas, MD, PhD, professor of ophthalmology and director of the Orbit and Thyroid Eye Disease Center at Cedars-Sinai, discusses results of the phase 3 OPTIC study and what a potential approval of teprotumumab would mean for patients and physicians.
Read More
DocTalk Podcast: Using Social Media as a Physician at AAO 2019
October 14th 2019Edmund Tsui, MD, social media editor for Ophthalmology, discusses some of the common pitfalls and advantages in the manner some physicians and clinicians navigate social media on this episode of the DocTalk Podcast.
Read More
Dog Ownership Reduces Mortality Risk, Especially in Heart Attack Patients
October 8th 2019A new study which reviewed data on more than 3 million patients found dog ownership was associated with a 24% reduced risk of all-cause mortality and a 65% reduced risk of mortality after a heart attack.
Read More
Black, Ethnic Diabetics Less Likely to be Prescribed Newer Medications
October 7th 2019A recent study of primary practices in England found Asian patients were 15% less likely to be prescribed insulin, while black patients were half as likely to be prescribed a GLP-1 agonist or SGLT2 inhibitor.
Read More
DocTalk Podcast: Canagliflozin's Approval and SGLT2 Inhibitors with Dr. Bakris
October 7th 2019George Bakris, MD, professor of medicine at University of Chicago Medicine and member of CREDENCE steering committee, discusses the recent approval of canagliflozin and what it means for diabetic patients and their physicians.
Read More
FDA Accepts BLA for Viaskin Peanut
October 4th 2019The United States Food and Drug Administration has accepted a BLA for Viaskin Peanut from DBV Technologies for the treatment of peanut-allergic children ages 4 to 11, which previously withdrew a BLA in 2018 after request from the FDA requested additional data on its manufacturing procedures and quality controls.
Read More
Fruit Juices, Not Just Soda and Other Sugary Drinks Linked to Diabetes
October 4th 2019A new study from the Harvard T.H. Chan School of Public Health found increasing consumption of sugary beverages, including 100% fruit juices, by half a serving per day could increase a person's risk of diabetes by 16%.
Read More
High Fiber Diet Can Lower Cardiovascular Risk in Hypertensive Diabetics
October 4th 2019A recent study from the ACC Middle East Conference 2019 found patients with hypertension and type 2 diabetes who consume a high fiber diet had improvement in their blood pressure, cholesterol and fasting glucose.
Read More
Blood Cancer Drug Linked to Hypertension, Adverse Cardiovascular Events
October 3rd 2019A new study from the Ohio State University found the commonly-prescribed blood cancer drug ibrutinib was linked to new or worsening hypertension, which investigators suggest could contribute to an increase in other cardiovascular events.
Read More